CA Patent

CA2062370A1 — Pharmaceutical preparation

Assigned to Mect Corp · Expires 1992-09-08 · 34y expired

What this patent protects

ABSTRACT An anti-inflammatory drug comprising as the effective component at least one compound selected from the group consisting of colominic acid, partial hydrolysis products of colominic acid and pharmaceutically acceptable salts thereof. The drug is used as a drug for re…

USPTO Abstract

ABSTRACT An anti-inflammatory drug comprising as the effective component at least one compound selected from the group consisting of colominic acid, partial hydrolysis products of colominic acid and pharmaceutically acceptable salts thereof. The drug is used as a drug for renal diseases, a drug for hepatitis, an immunomodulator and a drug for inhibiting the chemotaxis of neutrophil.

Drugs covered by this patent

Patent Metadata

Patent number
CA2062370A1
Jurisdiction
CA
Classification
—
Expires
1992-09-08
Drug substance claim
No
Drug product claim
No
Assignee
Mect Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.